Found 11 matching trials
Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population PHASE3 The primary objective is to assess the systemic and local safety profile of...
Show More Location
Research Institute for Tropical Medicine
Learn More & Join Trial
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults PHASE1 This is a 2-Stage, Phase I/II Study to Assess the Safety, Reactogenicity, a...
Show More Location
Nucleus Network - Brisbane (Q Pharm)
Learn More & Join Trial
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX PHASE2 The purpose of this study is to determine non-inferiority in seroconversion...
Show More Location
Clinical Pharamacology Center
Learn More & Join Trial
Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults PHASE2 This is part of an ongoing effort to develop a satisfactory dengue vaccine:...
Show More Location
Multiple Locations
Treatments Being Tested
Bivalent CYD-1,3 Dengue (Vero) + Bivalent CYD-2,4 Dengue (Vero) Bivalent CYD-1,3 Dengue (Vero) + Bivalent CYD-2,4 Dengue (Vero) Tetravalent blending VDV-2/CYD-1,3,4 Dengue (Vero) Tetravalent CYD-1,2,3,4 Dengue (Vero) JE-VAX®: Japanese encephalitis virus vaccine inactivated + Tetravalent CYD-1,2,3,4 Dengue (Vero) Learn More & Join Trial
This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population PHASE4 This is an open-label, uncontrolled phase 4 study to assess the safety and ...
Show More Location
Institut für Spezifische Prophylaxe und Tropenmedizin
Learn More & Join Trial
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX PHASE3 The purpose of this study is to determine non-inferiority in seroconversion...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country PHASE3 This is a randomized, open-label Phase 3 study including children aged \>9 ...
Show More Location
Research Institute for Tropical Medicine - Clinical Research Division
Learn More & Join Trial
A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects. PHASE1 Phase 1 study to evaluate two doses of Alum Adjuvanted Zika Virus Purified ...
Show More Location
Walter Reed Army Institute of Research - Clinical Trials Center
Learn More & Join Trial
Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries PHASE3 The primary objective is to assess the safety profile of IC51 in a pediatri...
Show More Location
Tampa Clinical Research Inc.
Learn More & Join Trial
Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals. PHASE4 The aim of this study is to investigate the immune responses following a bo...
Show More Location
Medical University of Vienna
Learn More & Join Trial